(Nasdaq: CTKB) today announced the opening of a new innovation center in Bellevue, Washington, marking the relocation of its previous Seattle-area operations to a dedicated facility designed to ...

FREMONT, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- At CYTO 2026, the industry’s premier flow cytometry conference, spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) will showcase ...

Recognized as a pioneer in spectral flow cytometry, Cytek is the creator of the first commercialized fluorescence-based flow cytometry platform to achieve 40 colors – effectively shifting the paradigm ...

FREMONT, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- With cancer research and diagnostics driving the need for deeper, faster cellular insights, spectral flow cytometry leader Cytek Biosciences, Inc.

FREMONT, Calif. and BARCELONA, Spain, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, has signed an agreement with the Centre for ...

CTKB is the leader in full spectrum flow cytometry (FSFC). In its simplest form, flow cytometry analyzes samples for the kinds of cells or particles present and studies cells to determine their ...

FREMONT, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, announced today the introduction of the Cytek Orion™ reagent ...

KANSAS CITY, Kan.--(BUSINESS WIRE)--KCAS Bio continues to deliver against both growth objectives and more integrated customer service offerings. KCAS Bio has partnered with Crux Biolabs, a leading ...

Spectral flow cytometry has revolutionized flow cytometry for both cell analysis and cell sorting and is now the gold standard. Fueled by this technological advancement, investigators that use our ...

The 39th annual Congress, themed Cytometry: The Next Wave, will spotlight emerging technologies shaping the future of the field. Cytek continues to play a central role in that evolution, advancing ...